Acurx Pharmaceuticals, Inc. (ACXP)
3.14
+0.36
(+12.95%)
USD |
NASDAQ |
Apr 15, 16:00
3.07
-0.07
(-2.23%)
After-Hours: 20:00
Acurx Pharmaceuticals Research and Development Expense (Annual) : 1.834M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Apyx Medical Corp. | 3.373M |
| Quince Therapeutics, Inc. | 35.38M |
| Lantern Pharma, Inc. | 11.51M |
| Sensei Biotherapeutics, Inc. | 10.96M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |